| CRISPR Medicine | This is an overview of our news stories
DNA repair by a hitherto overlooked mechanism - non-homologous blunt-end joining – might lead to a new therapeutic strategy for Duchenne muscular...
Some of the best stuff we picked up around the internet
Erik Sontheimer, Professor and Vice Chair at the RNA Therapeutics Institute and at the University of Massachusetts Medical School talks to CRISPR...
In recent years, researchers have turned to gene editing to address the limitations of CAR T therapies. This roundup summarises the clinical-stage...
Professor Jin-Soo Kim, from the Center for Genome Engineering at the Republic of Korea’s Institute for Basic Science, struggled for years to edit...
This week’s clinical update looks at 3 clinical trials for the treatment of sickle cell disease (SCD), relapsed or refractory blood cancers and...
Almost complete efficiency of gene knock-in is achieved with a new CRISPR-based system developed by researchers from AstraZeneca. The system also...
